Davis Polk advised Novo Nordisk on the deal while Goodwin Procter represented Forma Therapeutics. Novo Nordisk announced its approximately $1.1 billion acquisition of Forma Therapeutics. Under the...
Novo Nordisk’s $1.1 Billion Acquisition of Forma Therapeutics
Advent International’s Fundraising
Goodwin advised Advent International on the deal. Advent International announced its fundraising for its flagship fund, Advent International GPE X. The fund reached its hard cap of...
Carlyle’s Acquisition of Abingworth
Goodwin Procter and Travers Smith advised Abingworth on the deal, while Debevoise & Plimpton advised Carlyle. Abingworth announced its proposed acquisition by global investment firm Carlyle (NASDAQ:...